SAREPTA THERAPEUTICS; INC. COM $39.78

up +1.63


19/6/2013 04:19 PM  |  NASDAQ : SRPT  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Get Trend Analysis Icon Get SRPT Trend Analysis - it has outperformed the S&P 500 by 868%

Partner Headlines

  1. Sarepta Therapeutics Drops on Fake Citron Tweet

    Benzinga

  2. UPDATE: Piper Jaffray Cuts PT to $35 on Sarepta Therapeutics on ...

    Benzinga

  3. The Best Small Cap Performers of 2012

    Benzinga

  4. UPDATE: Piper Jaffray Reiterates Sarepta Therapeutics at Buy on ...

    Benzinga

  5. BioMarin, Prestige Brands and Other Top Performing Health Care ...

    Benzinga

  6. Benzinga's M&A Chatter for Wednesday November 28, 2012

    Benzinga

  7. UPDATE: Burril Initiates Sarepta Therapeutics at Market Outperform ...

    Benzinga

  8. Sarepta Announces Collaboration for Development of Added ...

    Benzinga

  9. Mid-Morning Market Update: Markets Largely Flat; Hostess to ...

    Benzinga

  10. Mid-Day Market Update: Markets Slow Their Rally; JC Penney Spikes ...

    Benzinga

  11. Top Narrow Based Indexes For November 12, 2012

    Benzinga

  12. Sarepta Therapeutics Names Sandy Mahatme Senior Vice President, CFO

    Benzinga

  13. Benzinga's M&A Chatter for Tuesday October 23, 2012

    Benzinga

  14. Wedbush Securities Reiterates Outperform Rating, $70 PT on Sarepta ...

    Benzinga

  15. Sarepta Therapeutics to Present Additional 48-Week Data From the ...

    Benzinga

  16. Benzinga Mid-Morning Market Update

    Benzinga

  17. Sarepta soars on MD results

    Investors Business Daily

  18. Sarepta Stock Jumps On Muscular Dystrophy Drug Trial

    Investors Business Daily

  19. Sarepta Therapeutics Shares Jump 169% on Trial Results

    FOXBusiness

  20. Stocks Hitting 52-Week Highs

    Benzinga

  21. Morning Market Movers

    Benzinga

  22. Benzinga's Top Pre-Market Gainers

    Benzinga

  23. A Peek Into The Market Before The Trading Starts

    Benzinga

  24. Sarepta Therapeutics Announces Eteplirsen Meets Primary Endpoint

    Benzinga

  25. Benzinga's Top Pre-Market Gainers

    Benzinga

  26. Options Alert: Sarepta Therapeutics

    Benzinga

  27. Sarepta Therapeutics Gets FDA Fast Track Designation for Ebola Drug

    Benzinga

  28. Sarepta soars on upbeat report

    Investors Business Daily

  29. Sarepta Therapeutics (SRPT) Adds 17.3% on Reports of Positive ...

    At Market Intelligence Center

  30. Health Care Sector Wrap

    FOXBusiness

  31. LyondellBasell Industries, BP Prudhoe Bay Royalty Included in ...

    FOXBusiness

  32. Gap, Costco Wholesale Among Stocks Hitting 52-Week Highs Thursday

    FOXBusiness

  33. Health Care Sector Wrap

    FOXBusiness

  34. Stocks Hitting 52-Week Highs

    Benzinga

  35. Benzinga's Top Pre-Market Gainers

    Benzinga

  36. Benzinga's Top Initiations

    Benzinga

  37. Health Care Sector Wrap

    FOXBusiness

  38. Health Care Sector Wrap

    FOXBusiness

  39. Sarepta Therapeutics Receives Stop-Work Order from US Department ...

    Benzinga

  40. Test Results Show Unprecedented Achievement for Marburg Drug Candidate

    Benzinga

  41. Health Care Sector Wrap

    FOXBusiness

  42. Sarepta Therapeutics Regains NASDAQ Compliance

    Benzinga

  43. Sarepta More than Doubles on Promising Study of Muscular Dystrophy ...

    Benzinga
People viewing SRPT also viewed: , , , , , ,
Marketplace
Trading Center